ÂÜÀòÂÒÂ×

Brenda Vienneau is a Senior Director Financial Planning Analysis at Nuvalent, Inc. Brenda previously held roles such as Asset Finance Lead - Senior R&D Controller at Ipsen, Director of Clinical Financial Planning & Analysis at BeiGene, and Business Unit Controller at Hoffmann-La Roche. Brenda has a CPA/CMA degree from Chartered Professional Accountants of Canada and a Honours Bachelors of Business Administration from Wilfrid Laurier University.